Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Platelet-derived exosomes offer better regenerative therapy but face challenges in isolation and regulation.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Thermo-responsive polymers in nanoparticles enable targeted drug delivery and advanced therapies by releasing drugs at specific temperatures.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Neuroregulation is crucial for skin wound healing and can be targeted to improve recovery.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Nanotechnology offers promising new treatments for hair loss by improving targeted delivery and addressing key causes.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

The research found that specific stem cells maintain skin gland openings and that disrupting their activity can cause blockages or early cancer signs, indicating a need for targeted treatments.

New therapies for rare skin diseases show promise but need more research.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Liposomes can safely and effectively deliver substances to mouse hair follicles, potentially useful for human hair treatments.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Understanding different species' regeneration can improve mammalian healing.

Keratins are crucial for tissue strength, and mutations in keratin genes can lead to various diseases, highlighting the need for targeted therapies.